Oklo stock seen overvalued as Aurora and Groves One progress
Oklo, a microreactor developer, has seen divisive trading despite no commercial reactor deployments or meaningful revenue. Its Aurora unit is described as modular, but Groves One reached criticality for the first time in early August. The stock is viewed as overvalued around 153 times 2028 sales, with expectations of sideways to lower trading through end-2026.